Advertisement
Advertisement

AUTL

AUTL logo

Autolus Therapeutics plc - ADR

1.38
USD
Sponsored
-0.05
-3.85%
Jan 30, 15:56 UTC -5
Closed
exchange

After-Market

1.38

0.00
+0.36%

AUTL Earnings Reports

Positive Surprise Ratio

AUTL beat 14 of 27 last estimates.

52%

Next Report

Date of Next Report
Mar 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$25.27M
/
-$0.26
Implied change from Q3 25 (Revenue/ EPS)
+19.53%
/
-13.33%
Implied change from Q4 24 (Revenue/ EPS)
+87048.02%
/
+160.00%

Autolus Therapeutics plc - ADR earnings per share and revenue

On Nov 12, 2025, AUTL reported earnings of -0.30 USD per share (EPS) for Q3 25, missing the estimate of -0.23 USD, resulting in a -30.32% surprise. Revenue reached 21.14 million, compared to an expected 21.74 million, with a -2.73% difference. The market reacted with a -9.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 25.27 million USD, implying an decrease of -13.33% EPS, and increase of 19.53% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Autolus Therapeutics plc - ADR reported EPS of -$0.30, missing estimates by -30.32%, and revenue of $21.14M, -2.73% below expectations.
The stock price moved down -9.33%, changed from $1.50 before the earnings release to $1.36 the day after.
The next earning report is scheduled for Mar 18, 2026.
Based on 10 analysts, Autolus Therapeutics plc - ADR is expected to report EPS of -$0.26 and revenue of $25.27M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement